How Overseas OEMs Can Launch in India Without Building Their Own Factory
India can be attractive to an overseas medical device OEM, but building a factory at the beginning is rarely the fastest route. A phased partnership model can help the OEM understand regulatory requirements, validate local demand, generate early market feedback and start controlled manufacturing without heavy fixed cost. The goal is to enter India with discipline, not speed alone.
Start with product and regulatory mapping
The first step is to define intended use, classification assumptions, materials, patient-contact nature, sterilisation needs, labelling requirements and import-versus-local-manufacturing strategy. This work should happen before tooling or commercial commitments. A product that is simple in one market may need additional documentation, testing or labelling logic in India.
Use pilot builds before committing full CAPEX
A pilot build allows the OEM to test local assembly, user handling, doctor feedback, packaging, bench testing and logistics. It also helps identify whether the product should be imported as finished goods, locally assembled from imported critical components, or progressively localised through tooling and manufacturing in India.
Distribution should be connected to evidence
Distribution is strongest when the OEM has technical evidence, user feedback and clear positioning for India. Market trial data, hospital feedback, sample evaluation, price sensitivity and service expectations should feed into both the manufacturing plan and commercial plan.
Start with a regulatory and product gap review
Define whether India is a sales base, assembly base or manufacturing base
Use limited pilot production before commercial scale-up
Collect structured feedback from clinicians or users where appropriate
Build distribution around documented product value, not only price
How Medevis Healthtech supports OEMs
Medevis Healthtech can support overseas OEMs with phased Indian entry: technical review, local manufacturing strategy, prototype or pilot builds, cleanroom assembly, regulatory-support coordination and market feedback support through Indian clinical and distribution networks.
Comments